Related Experiment Video
Updated: Feb 7, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based
Gerhard Bauer1, Magdi Elsallab2, Mohamed Abou-El-Enein2
1University of California Davis, Institute For Regenerative Cures (IRC), Sacramento, California, USA.
Abstract:
The promise of stem cell (SC) therapies to restore functions of damaged tissues and organs brings enormous hope to patients, their families, loved ones, and caregivers. However, limits may exist for which indications SC therapies might be useful, efficacious, and safe. Applications of innovative therapies within regulatory boundaries and within the framework of controlled clinical trials are the norm in the scientific and medical community; such a system minimizes patient risk by setting a clear and acceptable safety and efficacy profile for new therapeutics before marketing authorization. This careful clinical validation approach often takes time, which patients suffering from terminal or debilitating diseases do not have. Not validated, unproven stem cell interventions (SCI) that promise a working treatment or cure for severe diseases have therefore found their way into the patient community, and providers of such treatments often take advantage of the public's willingness to pay large amounts of money for the misguided hope of a reliable recovery from their illnesses. We conducted a review of scientific publications, clinical case reports, and mass media publications to assess the reported cases and safety incidents associated with unproven SCI. The review also analyzes the main factors that were identified as contributing to the emergence and global rise of the "stem cell tourism" phenomenon. Stem Cells Translational Medicine 2018;1-10.
Insights
Unproven stem cell interventions (SCI) offer false hope and pose risks to patients seeking cures. This review examines safety incidents and factors driving "stem cell tourism" due to unvalidated therapies.
Area of Science:
- Regenerative Medicine
- Clinical Translation
- Medical Ethics
Background:
- Stem cell (SC) therapies hold promise for tissue repair but require rigorous validation for safety and efficacy.
- Unproven stem cell interventions (SCI) are marketed to patients with unmet medical needs, often exploiting hope for profit.
- The lengthy process of clinical trials contrasts with the urgent needs of patients with severe diseases.
Purpose of the Study:
- To review scientific and media reports on safety incidents linked to unproven stem cell interventions (SCI).
- To analyze the contributing factors behind the global rise of "stem cell tourism."
- To assess the risks associated with unvalidated stem cell treatments outside regulatory frameworks.
Main Methods:
- Systematic review of scientific publications.
- Analysis of clinical case reports.
- Examination of mass media publications.
Main Results:
- Documented safety incidents and adverse events associated with unproven SCI.
- Identification of key drivers for the global increase in "stem cell tourism."
- Evidence of exploitation of patient hope by providers of unvalidated therapies.
Conclusions:
- Unproven stem cell interventions pose significant risks and ethical concerns.
- Regulatory oversight and patient education are crucial to mitigate harm from unvalidated SCIs.
- Addressing the demand for unproven therapies requires a multi-faceted approach involving scientific, regulatory, and ethical considerations.
More Related Videos
Related Concept Videos
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Induced Pluripotent Stem Cells
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Adult Stem Cells
Data Reporting and Recording

